TCL Archive OCEANS Study: Avastin Shows Tumor Shrinkage in 79 Percent By Cancer History Project June 24, 2011
TCL Archive I-ELCAP Results Internally Inconsistent, Peter Bach Writes By Cancer History Project June 24, 2011
TCL Archive Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study By Cancer History Project June 24, 2011
TCL Archive First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors By Cancer History Project June 24, 2011
TCL Archive Telatinib Demonstrates Positive Results in First-Line Treatment By Cancer History Project June 24, 2011
TCL Archive Barret’s Less of a Risk Factor For Cancer of the Esophagus By Cancer History Project June 24, 2011
TCL Archive New Abiraterone Acetate Results Show Greater Benefit Than Before By Cancer History Project June 24, 2011
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
